Zai Lab Ltd
Company Profile
Business description
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
Contact
4560 Jinke Road
Jinchuang Plaza, Building 1, 4th Floor
Pudong
Shanghai 201210
CHNT: +86 2161632588
E: billy.cho@zailaboratory.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
2,175
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 7,906.60 | 69.20 | 0.88% |
CAC 40 | 8,093.90 | 5.66 | 0.07% |
DAX 40 | 18,141.10 | 19.91 | -0.11% |
Dow JONES (US) | 38,239.66 | 153.86 | 0.40% |
FTSE 100 | 8,178.33 | 38.50 | 0.47% |
HKSE | 17,746.91 | 95.76 | 0.54% |
NASDAQ | 15,927.90 | 316.14 | 2.03% |
Nikkei 225 | 37,934.76 | 306.28 | 0.81% |
NZX 50 Index | 11,916.24 | 111.15 | 0.94% |
S&P 500 | 5,099.96 | 51.54 | 1.02% |
S&P/ASX 200 | 7,637.40 | 61.50 | 0.81% |
SSE Composite Index | 3,113.04 | 24.41 | 0.79% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
The Star Entertainment Group Ltd SGR | 0.42 | 0.03 | 6.41% |
Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
Droneshield Ltd DRO | 0.80 | 0.04 | -4.22% |
Mesoblast Ltd MSB | 1.09 | 0.16 | 16.67% |
South32 Ltd S32 | 3.51 | 0.14 | 4.15% |
Pilbara Minerals Ltd PLS | 3.96 | 0.16 | 4.21% |
Telstra Group Ltd TLS | 3.66 | 0.02 | 0.55% |
Northern Minerals Ltd NTU | 0.03 | 0.00 | 6.25% |
Jupiter Mines Ltd JMS | 0.32 | 0.02 | 5.00% |
Imugene Ltd IMU | 0.08 | 0.00 | 3.80% |